English
Received 17.10.2024, Revised 27.01.2025, Accepted 26.02.2025
In pharmaceutical practice, glass containers are subject to mandatory cleaning before filling. The presence of dust, microorganisms or other contaminants significantly affects the quality of the medicinal product, in particular, reducing its effectiveness. Proper preparation of containers ensures the safety of medicines and their preservation throughout the entire shelf life. The purpose of the study was to evaluate the effectiveness of glass vial preparation on an automatic washing machine as part of qualification tests to confirm its compliance with production standards. The preparation of vials for bottling included disinfection, soaking, rinsing, washing, drying, depyrogenation, and sterilisation using automated washing machines. Site Acceptance Tests ensured that the equipment worked properly after installation. They included an analysis of the technical documentation, parameters of communication systems and control units of the washing machine. Residual contaminants such as sodium chloride, alkalis, and riboflavin were tested to assess the efficiency of the washing process. Based on the results, a seven-step procedure was defined, which included ultrasonic cleaning, rinsing with purified water, and a final rinse with injection water. These cycles have proven to be effective in the preparation of sterile drug containers. Recommendations for optimising process parameters, such as duration, temperature, chemical composition, and mechanical action, have helped to maximise productivity and minimise maintenance costs. A modern approach in compliance with international ISO standards ensured the high quality of vial preparation. The automated washing machine proved its efficiency, optimised the cleaning process, reduced the risk of contamination, and guaranteed the reliability of packaging preparation for sterile medicines
glass containers for pharmaceutical use; bottle washing machine; site acceptance tests (SAT); user requirement specification (URS); fluorescence test for cleanability
[1] Chen, Y., et al. (2023). Optimization of key energy and performance metrics for drug product manufacturing. International Journal of Pharmaceutics, 631, article number 122487. doi: 10.1016/j.ijpharm.2022.122487.
[2] Dhoke, S. (2023). Determination of alkalinity in the water sample: A theoretical approach. Chemistry Teacher International, 5(3), 283-290. doi: 10.1515/cti-2022-0052.
[3] Ditter, D., Mahler, H.-C., Gohlke, L., Nieto, A., Roehl, H., Huwyler, J., Wah, M., & Allmendinger, A. (2018). Impact of vial washing and depyrogenation on surface properties and delamination risk of glass vials. Pharmaceutical Research, 35(7), article number 146. doi: 10.1007/s11095-018-2421-6.
[4] European Commission. (2013-2014). Good Manufacturing Practice (GMP) guidelines. Retrieved from https://health. ec.europa.eu/medicinal-products/eudralex/eudralex-volume-4_en.
[5] EU guidelines for good manufacturing practice for medicinal products for human and veterinary use. (2015, March). Retrieved from https://health.ec.europa.eu/system/files/2016-11/2015-10_annex15_0.pdf.
[6] ISO 8362-1:2018. (2018). Injection containers and accessories. Retrieved from https://www.iso.org/standard/74398.html.
[7] Jameel, F., et al. (2021). Recommended best practices for lyophilization validation part II: Process qualification and continued process verification. AAPS PharmSciTech, 22, article number 266. doi: 10.1208/s12249-021-02107-6.
[8] Kuzmina, H.I., & Strokan, A.P. (2013). Modern trends in quality assurance in pharmaceutical industry enterprises. Bulletin of the Khmelnytskyi National University, (3), 144-147.
[9] Lindboe, W.G. (2021). Validation of container preparation processes. In Handbook of validation in pharmaceutical processes (pp. 517-525). Boca Raton: CRC Press. doi: 10.1201/9781003163138.
[10] Liu, F., & Hutchinson, R. (2024). Visible particles in parenteral drug products: A review of current safety assessment practice. Current Research in Toxicology, 7, article number 100175. doi: 10.1016/j.crtox.2024.100175.
[11] Lopolito, P., Houtte, O., & Dion, M. (2017). Cleaning validation considerations for automated washing systems. Pharmaceutical Engineering, 37(2), 48-54.
[12] Nesterchuk, M.M., Lebedynets, V.O., & Bursakov, A.V. (2009). Qualification of equipment in pharmaceutical profile laboratories. Management, Economics, and Quality Assurance in Pharmacy, 6(8), 17-22.
[13] Panighello, S., & Pintori, G. (2024). Advanced surface techniques meet chemical analysis: Shedding light on parenteral containers. Journal of Non-Crystalline Solids, 639(6), article number 123092. doi: 10.1016/j.jnoncrysol.2024.123092.
[14] Pearson, J.T., & Elstob, C.M. (1970). Potentiometric determination of sodium using a sodium ion responsive glass electrode. Journal of Pharmacy and Pharmacology, 22(2), 73-80. doi: 10.1111/j.2042-7158.1970.tb08395.x.
[15] Saliy, O.O., Kuzmina, H.I., & Pavliuk, K.R. (2019). The connection of the philosophies lean manufacturing and GMP for the assurance of the quality of medicinal drugs. Physical and Organic Chemistry, Pharmacology and Pharmaceutical Technology of Biologically Active Substances: Collection of Scientific Works, 2(2), 27-137.
[16] Salo, S., Friis, A., & Wirtanen, G. (2008). Cleaning validation of fermentation tanks. Food and Bioproducts Processing, 86(3), 204-210. doi: 10.1016/j.fbp.2007.10.019.
[17] Sampathkumar, K., & Kerwin, B.A. (2024). Roadmap for drug product development and manufacturing of biologics. Journal of Pharmaceutical Sciences, 113(2), 314-333. doi: 10.1016/j.xphs.2023.11.004.
[18] Schaut, R.A., Peanasky, J.S., DeMartino, S.E., & Schiefelbein, S.L. (2014). A new glass option for parenteral packaging. PDA Journal of Pharmaceutical Science and Technology, 68(5), 527-534. doi: 10.5731/pdajpst.2014.00998.
[19] Shinde, S.J., Jain, P.S., & Kale, N.K. (2014). Critical review on qualification of sterilization equipment in aseptic processing. Journal of Pharmaceutical and BioSciences, 1, 24-35.
[20] Shoturma, P. (2024). Pharmaceutical industry review. Retrieved from https://promoboz.com/en/journal/2024/2-101may/spetsyfikatsiya-vymog-korystuvacha/#.
[21] Teska, B.M., Brake, J.M., Tronto, G.S., & Carpenter, J.F. (2016). Aggregation and particle formation of therapeutic proteins in contact with a novel fluoropolymer surface versus siliconized surfaces: Effects of agitation in vials and in prefilled syringes. Journal of Pharmaceutical Sciences, 105(7), 2053-2065. doi: 10.1016/j.xphs.2016.04.015.
[22] U.S. Food and Drug Administration. (2024). Drug product containers and closures. Retrieved from https://www.ecfr. gov/current/title-21/part-211/section-211.94.
[23] VDMA. (2007). Riboflavin test for low-germ or sterile process technologies. Retrieved from https://www.vdma.org/ documents/34570/15118518/Information_Sheet_Riboflavintest_Sterile_VT_2007_12_R2.pdf/77f86630-403d-25efbb2c-41c986b8513f?t=1623850110891/1000.
[24] Yakovenko, V.K., Heorhiiants, V.A., & Dorovskyi, O.V. (2015). Approaches to the qualification of the design of spectrophotometric equipment used in the analysis of herbal medicinal products. Ukrainian Biopharmaceutical Journal, 41(6), 53-59.
[25] Yoneda, S., Torisu, T., & Uchiyama, S. (2021). Development of syringes and vials for delivery of biologics: Current challenges and innovative solutions. Expert Opinion on Drug Delivery, 18(4), 459-470. doi: 10.1080/17425247.2021.1853699.
Українська